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Regarding “Heparin-bonded Dacron or
polytetrafluoroethylene for femoro-popliteal bypass
grafting: A multicenter trial”
We have read with interest the article by Devine and
McCollum (J Vasc Surg 2001;33:533-9) on femoropopliteal arte-
rial reconstructions comparing heparin-bonded Dacron grafts
versus non–heparin-treated PTFE control grafts. The title of this
important study suggests that the improved outcome demon-
strated for the heparin-bonded Dacron grafts is related somehow
to the antithrombotic properties of the bonded heparin that is
exposed on the inner graft surface to the circulating blood stream.
This assumption is well in line with previous work demonstrating
improved thrombo-resistance for heparin surface coated devices
exposed to the blood stream under various conditions.1-3
Unfortunately, clot production has been demonstrated clini-
cally for patients perfused with heparin-coated devices, after infu-
sion of protamine during the perfusion period.4 It was also
demonstrated for the experimental set-up that heparin-coated
devices exposed to circulating protamine produced more clots
than both uncoated controls perfused sequentially under the
same conditions and heparin surface coated devices perfused
without systemic heparinization.5 Hence, it has to be accepted
that circulating protamine neutralizes the antithrombotic proper-
ties of heparin surface treatments.
Devine and McCollum have not reported the detailed
periprocedural anticoagulation regimens used for the study group
receiving heparin-bonded grafts and the control patients included
in their report (only aspirin 300 mg/d is mentioned). However,
if some systemic heparin was given before cross-clamping, and
eventually protamine was used at the end of the procedure, it can
be expected, based on the experiences mentioned above, that the
heparin on the inner graft surface, which was exposed to circulat-
ing protamine, was neutralized, and therefore the antithrombotic
properties of the inner graft surface were lost. Hence, under such
circumstances it seems to be unrealistic to attribute the superior
patency rates of the study group to bonded heparin.
On the other hand, if the authors have avoided protamine in
the patients of the study group, this should be clearly stated, and
a caveat mentioning the downsides of protamine application in
the presence of heparin-bonded synthetic grafts seems to be
appropriate for the readers of the Journal.
Ludwig K. von Segesser, MD, FACS, FETCS
Bettina Marty, MD
Michel Hurni, MD
Department of Cardiovascular Surgery
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Switzerland
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Reply
Dr Von Segesser and colleagues read more into our title than
was intended. This was a clinical trial comparing two types of
grafts. Our discussion points out that we have no convincing evi-
dence to attribute the improved results with heparin-bonded
Dacron to the heparin bonding. Rather, we suggest that the
results with PTFE are poor, particularly with respect to subsequent
amputation.
It is normal practice in the UK to give heparin systemically
prior to applying cross clamps. However, some surgeons give
regional heparin only and heparin saline was infused into the dis-
tal tree after making the arteriotomy in 16 of the 209 recon-
structions. It is not normal practice in the UK to give protamine
and none of our patients received protamine.
We agree that it would be illogical to give protamine to any
patient in whom a heparin bonded device was being implanted.
We know that protamine reversal of heparin may be disastrous in
carotid surgery (Fearn SJ, Parry AD, Picton AJ, Mortimer AJ,
McCollum CN. Eur J Vasc Endovasc Surg 1997;13:394-7), but I
suspect there is little evidence of an effect on distal arterial recon-
struction.
Carol Devine, BA (hons)
Charles McCollum, MD, FRCS
University Hospital of South Manchester
Manchester, United Kingdom
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Regarding “The 50th anniversary of abdominal
aortic reconstruction”
Landmark events in medicine are usually grounded in the
thought and research of many people. Without taking credit from
Dubost, Oudot, and their colleagues for their audacity and inge-
nuity in performing the first aneurysm repair, one should also give
credit to the mentor who likely guided them. Given the state of
surgical technology and anesthesia in 1950, it took incredible
courage to apply what was only a minimal laboratory experience
with aortic homografts to a new clinical application. Was there
someone who provided inspiration to perform that surgery?
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That guide was likely Jean Patel, MD, Chef de Service of the
Hotel-Dieu, Paris. Patel is credited for his advice by Dubost in the
discussion section of the first aneurysm report. He was teacher to a
generation of surgical leaders in France. Unfortunately, Patel has
remained virtually unknown outside of the French-speaking world.
This remarkable surgeon lived from 1900 to 1968.1,2
Although his abiding interest later in life was surgery of the
spleen, he published widely (some 330 attributions overall),
including articles on traumatology, hepatectomy, and intestinal
problems. Relating to cardiac problems, he published reports in
the 1940s on surgery for constrictive pericarditis, aortopul-
monary transposition, aortic coarctation, and sympathectomy for
hypertension.
In the laboratory, Patel began studies of peripheral arterial
emboli in 1932. He and his colleagues developed an experience
with aortoiliac thrombectomy and embolectomy and used a
retroperitoneal approach.3 This approach was logically extended
by Dubost in his operation. Patel was directly involved in the con-
cept of homografting. In 1951, with Jean Natali, he performed a
series of 10 grafts in a canine model, and a report later docu-
mented the status of a graft with 10-year follow-up.4 In the
1960s, Patel went on to publish a series on infrarenal aneurysm
repairs,5 a study on renal artery aneurysms,6 and a study on the
role of endoaneurysmorrhaphy for peripheral aneurysms.7 Other
significant papers published by Patel included experiences in the
management of diabetic peripheral vascular disease8 and the use
of streptokinase for arterial occlusions.9 History has shown that a
group of French surgeons founded what must be regarded as a
school of vascular surgery that was at the absolute forefront of
development of this specialty from the 1930s until the late 1950s,
and Patel was a leader in that group.
Despite his ingenuity in the development of surgery for
aortic aneurysms, Jean Patel’s name does not appear in the ear-
liest bibliographies from the 1950s of reports in English relat-
ing to aortic surgery. Although Natali cited work with Patel in
his memoir of Oudot, he never discussed the role Patel had as
chief during those early days of vascular reconstruction.10 That
anonymity continues to the present. Patel was, of course, well
known in Europe as one of the most distinguished surgeons of
his time. In a world where travel was slower and English yet to
be acknowledged the lingua franca of medicine, Patel remained,
in a real sense, isolated from a large portion of the world med-
ical community. He spoke virtually no English, and his works
were not translated from French. He disliked travel in general
and had an aversion to airplanes. He formed some close friend-
ships with some American surgeons during World War II, but
he visited the United States only once, when his son was a
Fulbright Scholar.
At the 50th anniversary of surgery for aortic aneurysms, Jean
Patel deserves recognition as a guide who inspired the pioneering
use of aortic homografts and retroperitoneal exposure in the first
aortic reconstructions. He is truly an unsung hero who helped
found the specialty of vascular surgery.
Jeffrey L. Kaufman, MD
Vascular Services of Western New England
Springfield, Mass
This account is based in part on correspondence with Jean
Patel’s sons, Dr Jean-Claude Patel and Dr Alain Patel, as well as
Dr Georges Arnulf and Dr Jean Natali, all of whom kindly shared
material published at the death of Dr Jean Patel. Dr Allan Callow
also provided important insights about the importance of Dr
Patel.
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Regarding “The influence of surgical specialty
training on the outcomes of elective abdominal aortic
aneurysm surgery”
I appreciated the article by Drs Tu, Austin, and Johnston 
(J Vasc Surg 2001;33:447-52) and Dr Cronenwett’s related com-
mentary (654-6). Dr Cronenwett refers to “low volume surgeons”
and “certified vascular surgeons” but does not speak to the realm
in between—the high-volume, noncertified vascular surgeon.
It has been suggested that specialty training in vascular pro-
cedures leads to better patient outcomes.1,2 Actual procedure vol-
ume after training has not particularly been shown to correlate.3,4
Beneath the surface of the controversy regarding an independent
Board of Vascular Surgery is another, perhaps more important,
nascent dispute, that being the ideal that Board Certification
equals competence.
At the Lehigh Valley Hospital in Allentown, Pa, six surgeons
whose practices are limited to vascular surgery perform the bulk
of vascular procedures (>90%). Four of the six are in one practice
group, and the other two are in a separate group. All completed
vascular fellowships. One member of each group does not have
board certification in vascular surgery.
Inspired by Dr Norman Hertzer, the Lehigh Valley Hospital
in Allentown, Pa, has had a vascular registry since 1991. Every
patient having a carotid, aortic, or lower-extremity bypass proce-
dure is entered into the registry in order to follow outcomes.
Every surgeon performing those operations is examined for sev-
eral criteria. For example, in carotid surgery, surgeon-specific
morbidity and mortality rates are easily identified.
A review of elective aortic surgery reveals a mortality rate for
the two noncertified vascular surgeons of 1.6% (4/247) and a rate
of 1.8% (8/435) for the four certified vascular surgeons. For rup-
tured abdominal aneurysms, the corresponding rates are 30%
(7/23) and 32% (15/47), respectively. Carotid morbidity and
mortality rates are 1.2% (8/655) and 1.4% (18/1275), respec-
tively. Severity of illness scores are equal for each group. Age and
gender bias also did not exist between the groups. The American
College of Surgeons has taken the initiative to describe the com-
petent physician and, of course, certification is a major facet of
that recognition.5
